Review b1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond

Abstract

Angiogenesis is an important tissue-level program supporting the growth of highly aggressive cancers and early-stage metastases. However, rapid emergence of resistance to antiangiogenic therapies, such as bevacizumab, greatly limits the clinical utility of these promising approaches. The mechanisms of resistance to antiangiogenic therapy remain incompletely… (More)

Topics

1 Figure or Table

Cite this paper

@inproceedings{Jahangiri2013ReviewBI, title={Review b1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond}, author={Arman Jahangiri and Manish K Aghi and W. Shawn Carbonell}, year={2013} }